MoneyWorks4Me

Suven Life Sciences informs about press release

07 Dec 2015 Evaluate

Suven Life Sciences has informed about a Press Release dated December 07, 2015 titled ‘Suven Initiates Phase 2A trial of SUVN-502 in USA in Alzheimers Disease’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..